AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2025 Earnings Call Transcript
Operator: Good morning. Welcome to the AngioDynamics Fiscal Year 2025 Second Quarter Earnings Call. At this time, all participants are in a listen-only mode.
Angiodynamics Inc (ANGO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 2,162,568 | $19,809,123 | -4% | 0% |
| 2. | Royce & Associates Chuck Royce | 1,119,385 | $10,253,567 | +14% | 0.09% |
| 3. | Renaissance Technologies Jim Simons | 913,029 | $8,363,346 | -14% | 0.01% |
| 4. | Armistice Capital Steven Boyd | 872,000 | $7,987,520 | -10% | 0.1% |
| 5. | Citadel Investment Group Ken Griffin | 815,826 | $7,472,966 | +345% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.08 | 100 | 45,877 | 2024-10-10 | Filing | ||
| $6.09 | 768 | 45,777 | 2024-10-07 | Filing | ||
| $5.86 | 1,700 | 172,711 | 2024-10-08 | Filing | ||
| $6.03 | 20,000 | 681,582 | 2024-10-07 | Filing | ||
| $6.70 | 10,000 | 539,066 | 2024-04-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.31 | 4,060 | 41,817 | 2025-01-16 | Filing | ||
| $12.95 | 4,633 | Officer | 19,189 | 2023-01-31 | Filing | |
| $22.44 | 5,000 | Officer | 23,822 | 2022-07-29 | Filing | |
| $22.44 | 3,513 | Officer | 22,874 | 2022-04-28 | Filing | |
| $23.26 | 1,299 | Director | 79,704 | 2022-04-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,941,630 | $36,105,331 | 0% | |
| 2. | 2,521,065 | $23,092,981 | 0.59% | |
| 3. | 2,292,619 | $21,000,390 | 0% | |
| 4. | 1,488,667 | $13,636,023 | 0% | |
| 5. | 1,415,156 | $12,962,829 | 0.17% |
News See All
AngioDynamics, Inc. (NASDAQ:ANGO) Q1 2025 Earnings Call Transcript
Operator: Good morning and welcome to the AngioDynamics Fiscal Year 2025 First Quarter Earnings Call. At this time all participants are in listen-only mode.
AngioDynamics, Inc. (NASDAQ:ANGO) Q4 2024 Earnings Call Transcript
Operator: Good morning and welcome to the AngioDynamics fiscal year 2024 Fourth Quarter Earnings Call. At this time, all participants are in a listen-only mode.
5 Micro-Cap Healthcare Stocks Insiders Are Buying
This article presents an overview of 5 Micro-Cap Healthcare Stocks Insiders Are Buying. For a detailed overview of such stocks read our article, 10 Micro-Cap Healthcare Stocks Insiders Are Buying...
AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2024 Earnings Call Transcript
AngioDynamics, Inc. misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $-0.14. AngioDynamics, Inc.
AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2024 Earnings Call Transcript
AngioDynamics, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.09.
AngioDynamics, Inc. (NASDAQ:ANGO) Q1 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the AngioDynamics Fiscal Year 2024 First Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
AngioDynamics, Inc. (NASDAQ:ANGO) Q4 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the AngioDynamics Fourth Quarter and Fiscal Year 2023 Earnings Call. At this time, all participants are in a listen-only mode.
AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the AngioDynamics Fiscal Year 2023 Third Quarter Earnings Call. At this time, all participants are in a listen-only mode.
AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the AngioDynamics Fiscal Year 2023 Second Quarter Earnings Call. At this time all participants are in listen-only-mode.
Billionaire Hedge Funds
